Similar Search Results

Agent Sorting by Incentive Systems in Mission Firms : Implications for Health Care and Other Credence Goods Markets

Green, Ellen; Kloosterman, Andrew - 2019

Intrinsic motivation and monetary incentives affect an expert's choice of firm, and thus also the performance of the …

Persistent link: https://www.econbiz.de/10014102970

The impacts of private hospital entry on the public market for elective care in England

Kelly, Elaine; Stoye, George - 2020

This paper examines the impacts of private hospital entry on publicly funded elective care in England. From 2006, private hospitals were encouraged to enter certain publicly funded markets to compete with existing public hospitals and stimulate quality improvements. Studying elective hip...

Persistent link: https://www.econbiz.de/10012149593

Entry and exit of physicians in a two-tiered public/private health care system

Gächter, Martin; Schwazer, Peter; Theurl, Engelbert - 2011

Firm turnover has recently attracted increased interest in economic research. The entry of new firms increases competition and promises efficiency gains. Moreover, changes in the market structure influence productivity growth, because firm entry usually leads to increased innovation. The health...

Persistent link: https://www.econbiz.de/10009737067

The national regulation of pharmaceutical markets and the timing of new drug launches in Europe

Heuer, Alexander (contributor); Mejer, Malwina (contributor) - 2007

We analyze the impact of national pharmaceutical regulation on the launch delay of new chemical entities approved by the EMEA's centralized procedure. We find that direct price control regimes have a significantly negative impact on the launch timing. These results cannot be found when...

Persistent link: https://www.econbiz.de/10003471161

Entry and exit of physicians in a two-tiered public/private health care system

Gächter, Martin; Schwazer, Peter; Theurl, Engelbert - 2011

Persistent link: https://www.econbiz.de/10011344853

Biologic Drugs, Biosimilars, and Barriers to Entry

Shepherd, Joanna - 2014

Biologic drugs represent an important category of drugs that improve health outcomes in this country. Yet, these cutting-edge drugs are often prohibitively costly, preventing access for many Americans. Recognizing the need for more affordable, generic substitutes for biologic drugs — or...

Persistent link: https://www.econbiz.de/10014148056

Patents, Price Controls and Access to New Drugs : How Policy Affects Global Market Entry

Lanjouw, Jean O. - 2014

We consider how patent rights and price regulation affect whether new drugs are marketed in a country, and how quickly. The analysis covers a large sample of 68 countries at all income levels and includes all drug launches over the period 1982-2002. It uses newly compiled information on legal...

Persistent link: https://www.econbiz.de/10014026156

The Impact of the Entry of Biosimilars : Evidence from Europe

Scott Morton, Fiona M.; Stern, Ariel Dora; Stern, Scott - 2019

Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry, however only a few biosimilars have been approved in the US since 2015, thereby largely preserving biologics...

Persistent link: https://www.econbiz.de/10014126235

U.S. Healthcare : A Story of Rising Market Power, Barriers to Entry, and Supply Constraints

Weber, Anke; Lin, Li; Mrkaic, Mico - 2022

Healthcare in the United States is the most expensive in the world, with real per capita spending growth averaging 4 percent since 1980. This paper examines the role of market power of U.S. healthcare providers and pharmaceutical companies. It finds that markups (the ability to charge prices...

Persistent link: https://www.econbiz.de/10013306779

Empirische Erfahrungen, Versichertenverhalten zu steuern

Osmers, Henning; Vauth, Christoph - Wirtschaftswissenschaftliche Fakultät, Leibniz … - 2004

empirical inquiries. Researchers have found that mismanagement is often a consequence of misplaced incentives. This paper tries … incentives. An introduction is given as a short overview of the healthcare sector with its economical specialties. This is … followed by an outline of some well established contract models and their effect on the demander’s incentives. The paper …

Persistent link: https://www.econbiz.de/10005464729